There is no cure for PD. Worldwide, over 10 million people are afflicted with PD and the yearly mortality rate is greater than 100,000, globally.
International Stem Cell Corporation (ISCO), is the parent company of Lifeline Skin Care and has devoted many years of research to improve this terrible disease. The company has developed a unique method of creating human neural stem cells which when introduced into the brain, promote the recovery of dopaminergic neurons, the brain cells that are originally affected and cause the disease symptoms. ISCO’s preclinical studies showed that the administration of these neural stem cells was safe and improved motor symptoms. To date, 3 of the planned total of 12 patients, have entered the clinical trial and have received neural stem cells. At this point in time, all patients have been discharged from their hospital settings and are observed to be meeting clinical expectations.
Lifeline Skincare (LSC) – a subsidiary of ISCO – uses the extracts from human stem cells, (produced by ISCO), and developed for the skin in order to improve the signs of aging. The latest technology being used to advance a cure for PD is now available for the skin in a line of products produced by LSC. The profits from the sale of these skin care products go directly to ISCO in order to fund the development of a therapy for PD.
